ArthroCare Restatement Will Cut Up To $37 Million From ’06-’08 Sales Reports

Radiofrequency surgical instrument maker ArthroCare plans to restate previously filed financial statements from 2006-2008 to account for improper recording of sales to certain entities, resulting in a $26 million-$37 million reduction in previously recorded revenues

More from Archive

More from Medtech Insight